130 related articles for article (PubMed ID: 2622869)
1. Administration of activated charcoal or sodium polystyrene sulfonate (Kayexalate) as gastric decontamination for lithium intoxication: an animal model.
Linakis JG; Lacouture PG; Eisenberg MS; Maher TJ; Lewander WJ; Driscoll JL; Woolf AD
Pharmacol Toxicol; 1989 Nov; 65(5):387-9. PubMed ID: 2622869
[TBL] [Abstract][Full Text] [Related]
2. Effect of delayed treatment with sodium polystyrene sulfonate on serum lithium concentrations in mice.
Linakis JG; Hull KM; Lee CM; Maher TJ; Lewander WJ; Lacouture PG
Acad Emerg Med; 1995 Aug; 2(8):681-5. PubMed ID: 7584745
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of lithium elimination by multiple-dose sodium polystyrene sulfonate.
Linakis JG; Hull KM; Lacouture PG; Lockhart GR; Lewander WJ; Maher TJ
Acad Emerg Med; 1997 Mar; 4(3):175-8. PubMed ID: 9063542
[TBL] [Abstract][Full Text] [Related]
4. Multiple-dose sodium polystyrene sulfonate in lithium intoxication: an animal model.
Linakis JG; Eisenberg MS; Lacouture PG; Maher TJ; Lewander WJ; Driscoll JL; Woolf A
Pharmacol Toxicol; 1992 Jan; 70(1):38-40. PubMed ID: 1594533
[TBL] [Abstract][Full Text] [Related]
5. Sodium polystyrene sulfonate treatment for lithium toxicity: effects on serum potassium concentrations.
Linakis JG; Hull KM; Lacouture PG; Lockhart GR; Lewander WJ; Maher TJ
Acad Emerg Med; 1996 Apr; 3(4):333-7. PubMed ID: 8881542
[TBL] [Abstract][Full Text] [Related]
6. Potassium repletion fails to interfere with reduction of serum lithium by sodium polystyrene sulfonate in mice.
Linakis JG; Savitt DL; Trainor BJ; Young JE; Lacouture PG
Acad Emerg Med; 2001 Oct; 8(10):956-60. PubMed ID: 11581080
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of lithium toxicity with sodium polystyrene sulfonate: a retrospective cohort study.
Ghannoum M; Lavergne V; Yue CS; Ayoub P; Perreault MM; Roy L
Clin Toxicol (Phila); 2010 Jan; 48(1):34-41. PubMed ID: 19842945
[TBL] [Abstract][Full Text] [Related]
8. In vitro binding of lithium using the cation exchange resin sodium polystyrene sulfonate.
Watling SM; Gehrke JC; Gehrke CW; Zumwalt R; Pribble J
Am J Emerg Med; 1995 May; 13(3):294-6. PubMed ID: 7755820
[TBL] [Abstract][Full Text] [Related]
9. Use of sodium polystyrene sulfonate for reduction of plasma lithium concentrations after chronic lithium dosing in mice.
Linakis JG; Savitt DL; Wu TY; Lockhart GR; Lacouture PG
J Toxicol Clin Toxicol; 1998; 36(4):309-13. PubMed ID: 9711196
[TBL] [Abstract][Full Text] [Related]
10. Comparison of activated charcoal and sodium polystyrene sulfonate resin efficiency on reduction of amitriptyline oral absorption in rat as treatments for overdose and toxicities.
Yousefi G; Bizhani M; Jamshidzadeh A; Gholamzadeh S
Iran J Basic Med Sci; 2017 Jan; 20(1):46-52. PubMed ID: 28133524
[TBL] [Abstract][Full Text] [Related]
11. In vitro study of lithium carbonate adsorption by activated charcoal.
Favin FD; Klein-Schwartz W; Oderda GM; Rose SR
J Toxicol Clin Toxicol; 1988; 26(7):443-50. PubMed ID: 3148035
[TBL] [Abstract][Full Text] [Related]
12. Amitriptyline, clomipramine, and doxepin adsorption onto sodium polystyrene sulfonate.
Jamshidzadeh A; Vahedi F; Farshad O; Seradj H; Najibi A; Dehghanzadeh G
Daru; 2014 Jan; 22(1):21. PubMed ID: 24450391
[TBL] [Abstract][Full Text] [Related]
13. In-vivo binding of lithium using the cation exchange resin sodium polystyrene sulfonate.
Gehrke JC; Watling SM; Gehrke CW; Zumwalt R
Am J Emerg Med; 1996 Jan; 14(1):37-8. PubMed ID: 8630152
[TBL] [Abstract][Full Text] [Related]
14. Lithium absorption prevented by sodium polystyrene sulfonate in volunteers.
Tomaszewski C; Musso C; Pearson JR; Kulig K; Marx JA
Ann Emerg Med; 1992 Nov; 21(11):1308-11. PubMed ID: 1416323
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Sodium Polystyrene Sulfonate Dosing Strategies in the Inpatient Management of Hyperkalemia.
Mistry M; Shea A; Giguère P; Nguyen ML
Ann Pharmacother; 2016 Jun; 50(6):455-62. PubMed ID: 27048188
[TBL] [Abstract][Full Text] [Related]
16. Use of sodium polystyrene sulfonate in a lithium overdose.
Roberge RJ; Martin TG; Schneider SM
Ann Emerg Med; 1993 Dec; 22(12):1911-5. PubMed ID: 8239115
[TBL] [Abstract][Full Text] [Related]
17. Treatment of pediatric hyperkalemia with sodium polystyrene sulfonate.
Lee J; Moffett BS
Pediatr Nephrol; 2016 Nov; 31(11):2113-7. PubMed ID: 27215929
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of thallium adsorption by activated charcoal, prussian blue, and sodium polystyrene sulfonate.
Hoffman RS; Stringer JA; Feinberg RS; Goldfrank LR
J Toxicol Clin Toxicol; 1999; 37(7):833-7. PubMed ID: 10630266
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease.
Georgianos PI; Liampas I; Kyriakou A; Vaios V; Raptis V; Savvidis N; Sioulis A; Liakopoulos V; Balaskas EV; Zebekakis PE
Int Urol Nephrol; 2017 Dec; 49(12):2217-2221. PubMed ID: 29027620
[TBL] [Abstract][Full Text] [Related]
20. Effect of sodium polystyrene sulfonate on lithium bioavailability.
Bélanger DR; Tierney MG; Dickinson G
Ann Emerg Med; 1992 Nov; 21(11):1312-5. PubMed ID: 1416324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
